ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+39.12%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$208M
AUM Growth
+$91.4M
(+79%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
30.59%
Top 10 Holdings %
Top 10 Hldgs %
64.06%
Holding
34
New
14
Increased
9
Reduced
4
Closed
1
Top Buys
| 1 |
Insmed
INSM
|
+$10.8M |
| 2 |
DERM
Dermira, Inc.
DERM
|
+$8.63M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
+$6.87M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
+$5.83M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$4.82M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
+$7.27M |
| 2 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
+$1.92M |
| 3 |
Veracyte
VCYT
|
+$1.53M |
| 4 |
Iovance Biotherapeutics
IOVA
|
+$713K |
| 5 |
Outlook Therapeutics
OTLK
|
+$15K |
Sector Composition
| 1 | Healthcare | 86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
26
Amarin Corp
AMRN
$310M
| $1.82M | 0.86% |
4,375
-17,500
| -80% | -$7.27M |
|
27
Gossamer Bio
GOSS
$787M
| $1.3M | 0.62% |
+60,000
| New | +$1.3M |
|
|
ALLK
28
DELISTED
Allakos
ALLK
| $547K | 0.26% |
+13,500
| New | +$547K |
|
29
Sutro Biopharma
STRO
$77.2M
| $518K | 0.25% |
45,500
| – | – |
|
|
CEMI
30
DELISTED
Chembio diagnostics, Inc.
CEMI
| $231K | 0.11% |
41,667
-345,500
| -89% | -$1.92M |
|
31
BioCryst Pharmaceuticals
BCRX
$1.68B
| $204K | 0.1% |
25,000
| – | – |
|
32
Novavax
NVAX
$1.34B
| – | – |
0
| – | – |
|
|
33
Outlook Therapeutics
OTLK
$48.4M
| – | – |
-182
| Closed | -$15K |
|
34
SPDR S&P Biotech ETF
XBI
$5.52B
| – | – |
0
| – | – |
|